asccp pap guidelines algorithm 2021minion copy and paste
Screening recommended every 3 years for women 21-29. 6) The last screen shows the guidelines information for this patient. Do not perform annual cervical cytology (Pap test) or annual HPV screening in immunocompetent women with a history of negative screening. test (to determine the presence/absence of HPV 16/18), and also a reflex cytology test to determine whether the Squamous Intraepithelial Lesion (SIL): A term used to describe abnormal cervical cells detected by the Pap test. Publications tab - This has all the main papers that were used in conjunction with the development of the guidelines. Schiffman M, Wentzensen N, Perkins RB, Guido RS. Epub 2020 May 23. When you look at the American Society for Colposcopy and Cervical Pathology (ASCCP) guideline flowsheets, it can seem like an absolute maze, and remembering what to do when is challenging. Accessibility *For nonpregnant patients 25 years or older. Risk tables have been generated to assist the clinician and guide practice. development of the applications. Similarly, if a patient had a high-grade cytology result, including atypical squamous cells cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) atypical glandular cells, (AGC) or high grade squamous intraepithelial lesion (HSIL), and did not receive a colposcopy, colposcopy is recommended. Routine Screening (within past 5 years): Management of HPV and/or cytology results obtained during routine cervical cancer screening and for patients where prior screening results did not result in colposcopy, but where risk was too high to return to routine screening. 1192 0 obj <>stream %PDF-1.5 Xiong S, Lazovich A, Hassan F, Ambo N, Ghebre R, Kulasingam S, Mason SM, Pratt RJ. More frequent surveillance, colposcopy, and treatment are The new Risk-Based Management Consensus Guidelines have several important differences from the 2012 Guidelines, endobj Methods: HSIL Pap cases with hrHPV co-testing were retrospectively reviewed from June 2015 to September 2020 in our archive. Bulk pricing was not found for item. 21 to 29 years of age *. endstream endobj startxref Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories. Risk Based Management Guidelines Creator: Stella Bebos Updated: 10/12/2021 Contains: 11 items Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors Perkins, Rebecca B.; Guido, Richard S.; Castle, Philip E.; More 1. All rights reserved. Primary HPV testing: testing with HPV testing alone as a screening or surveillance test. Terminology for pap results NIL- no cell lesions or malignancy noted ASCUS- atypical cells of undetermined significance LSIL- low-grade squamous intraepithelial lesion ASC-H- changes in cervical cells have been seen, cannot rule out HSIL HSIL- high-grade intraepithelial lesion AGUS- atypical glandular cells of undetermined significance Consistent with prior guidance, screening should begin at age 21 years, and screening recommendations remain unchanged for average-risk individuals aged 21-29 years and those who are older than 65 years Table 1. Although most HPV infections are transient and subclinical, some lead to clinical manifestations ranging from benign papillomas or warts to intraepithelial lesions. Among patients who have undergone hysterectomy but either have no previous diagnosis of CIN 2+ within the previous 25 years or have completed the 25 year surveillance period, screening is generally not recommended. The corresponding authors had final responsibility for the submission decision. Conversely, if a patient has a negative HPV test or co-test following a low-grade result for which colposcopy was previously recommended but not performed, repeating an HPV test or co-test in 1 year is acceptable. Participating organizations supported travel for their participating representatives. )CQq]/iGxJh HxLEc&tfAx%%NEz"ZCHQ($ 33_ In patients 30 to 65 years of age, cervical cancer screening should be performed every three years using cervical cytology alone, every five years using high-risk HPV testing alone, or every five years using cotesting. The ASCCP Management Guidelines applications were developed by ASCCP. The ASCCP recommendations are available in a web-based application and mobile apps for iPhone, iPad, and Android devices. Rather than consider See this image and copyright information in PMC. 2020 Oct;24(4):425. doi: 10.1097/LGT.0000000000000561. Arguably, the scenarios described above would be higher risk, and therefore colposcopy is warranted. <>>> 2020 Oct;24(4):427. doi: 10.1097/LGT.0000000000000563. ACS/ASCCP/ASCP guidelines 1. incorporated past screening history. An HPV test looks for infection with the types of HPV that are linked to cervical cancer. Perkins RB, Guido RS, Castle PE, et al. patient's risk of progressing to precancer or cancer. J Low Genit Tract Dis. With more than 200 types identified, human papillomavirus (HPV) commonly causes infections of the skin and mucosa. specifically, the risk of a patient developing cervical cancer, estimated by the surrogate endpoint of the 5-year 2019 ASCCP risk-based management consensus guidelines for abnormal 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. What should we do to find out the next step for this patient? -, Huh WK, Ault KA, Chelmow D, et al. No industry funds were used in the development of these guidelines. The American College of Obstetricians and Gynecologists reviews its publications regularly; however, its publications may not reflect the most recent evidence. If HPV testing is not performed on ASC-US results, then repeat cytology in 6 to 12 months is recommended, with colposcopy referral for ASC-US or higher. In additional to enabling the provision of more individualized clinical care, the new risk-based management paradigm will facilitate the incorporation of new screening and management technologies into clinical decision making and accommodate changes in disease prevalence over time. Copyright 2023 American Academy of Family Physicians. ASCCP endorses the United States Preventative Services Task Force (USPSTF) cervical cancer screening guidelines. Would you like email updates of new search results? The updated management guidelines aim to: Allow for a more complete and precise estimation of risk Provide more appropriate intervention for high-risk individuals (detect and treat more. If you are 21 to 29 Have a Pap test alone every 3 years. 21 Clearly defined risk thresholds based on the results of HPV tests, alone or in conjunction with cytology, are used to guide management (more or . TRICIN: A Phase II Trial on the Efficacy of Topical TRIchloroacetic Acid in Patients with Cervical Intraepithelial Neoplasia. In this case, the patient had an ASCUS pap test result and a positive high risk test results. The overarching theme of the recommendations reflects a 'risk-based' strategy, rather than rigid focus on a particular result. of a positive screening test to inform the next steps in management. Federal government websites often end in .gov or .mil. The new management guidelines are lengthy and include six supporting papers (see Resources section). Clearly The risk database will continue to be updated as new testing methods and follow-up data emerge, and the new framework will allow management to be adjusted accordingly and consistently. MeSH This management is based on the findings that risk estimates did not reach the colposcopy threshold for an HPV-negative or co-test negative result following any previous low-grade result.3. Cotesting: this term refers to screening or surveillance performed with both cytology and HPV testing. All rights reserved. One study demonstrated that 31% of genital warts contain both low- and high-risk types of HPV.20. Updated guidelines were needed to incorporate these changes. ASCCP recently released its Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors 1 . The app is only to be used by medical professionals and email addresses will be retained under the terms of the privacy policy. Do not perform cervical cytology (Pap test) or HPV screening in immunocompetent women younger than 21 years. The management in these scenarios is based on the 2012 guidelines,2 which recommend colposcopy when a follow-up HPV test is positive or cytology is ASC-US or worse following a result of HPV-positive with negative cytology. With a more nuanced understanding of how prior results affect risk, and more We don't have any prior history in this particular case. 3 0 obj 1186 0 obj <>/Filter/FlateDecode/ID[<4119F28666E0954E9D1B9856E3FE9044>]/Index[1176 17]/Info 1175 0 R/Length 65/Prev 464723/Root 1177 0 R/Size 1193/Type/XRef/W[1 2 1]>>stream It does not apply to reflex HPV testing for triage of ASC-US Additional testing from the same laboratory specimen is recommended because the findings may inform colposcopy practice. time. HPV: this term refers to Human Papillomavirus. long-term utility of the guidelines. Specifically, the 2012 guidelines recommend colposcopy for all cytology results of low grade squamous intraepithelial lesion (LSIL) or higher for individuals aged 25 and above. Penis: The male sex organ. high-risk HPV types only. %PDF-1.6 % is an ASCCP consultant of Inovio Pharmaceuticals DSMB. This evaluation may include cervical cytology, colposcopy, diagnostic imaging, and cervical, endocervical, or endometrial biopsy. Scenario #2 A 26 year old patient. endstream endobj 105 0 obj <>/Metadata 6 0 R/Outlines 10 0 R/PageLabels 100 0 R/PageLayout/SinglePage/Pages 102 0 R/PieceInfo<>>>/StructTreeRoot 15 0 R/Type/Catalog>> endobj 106 0 obj <>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 90/StructParents 0/Type/Page/VP[<>]/D[<>]/R(1:1)/Subtype/RL/X[<. Smoking and alcohol cessation should be recommended to reduce the risk of HPV persistence and the development of HPV-related malignancies. 104 0 obj <> endobj So we enter both of them by simply touching them. Read all of the Articles Read the Main Guideline Article Management Guidelines time: Negative HPV test or cotest within 5 years. Conflict of interest: The following listed authors have no conflicts of interest to disclose: Drs. Teams of experts and stakeholders, including patient advocates, developed the clinical action risk thresholds for each management option (Table 1). 1176 0 obj <> endobj 4 0 obj high quality evidence, and in these situations the guidelines have, by necessity, been based on consensus expert Available at: ASCCP management guidelines app quick start guide. to routine screening. 2022 Dec 13;3(1):130. doi: 10.1186/s43058-022-00382-3. A history of multiple sex partners; initiation of sexual activity at an early age; not using barrier protection; other sexually transmitted infections, including HIV; an immunocompromised state; alcohol use; and smoking have been identified as risk factors for persistent HPV infections. Risk estimation will use technology, such as a smartphone application or website. ASCCP guidance informs the assessment and treatment of abnormal cervical cancer screening results. In cases where a colposcopy was previously recommended but not completed, if on repeat testing the patient has a persistent HPV-positive result and/or persistent cytologic abnormality (atypical squamous cells of uncertain significance, ASC-US, or higher), colposcopy is recommended. Any updates to this document can be found on www.acog.orgor by calling the ACOG Resource Center. endstream endobj 1177 0 obj <. 0 409 12th Street SW, Washington, DC 20024-2188, Privacy Statement 2012 Jul;16(3):175-204. doi: 10.1097/LGT.0b013e31824ca9d5. Before Copyright, 2002, 2006, 2013, 2019, 2020 ASCCP. 2020 Oct;24(4):426. doi: 10.1097/LGT.0000000000000562. Please try again soon. ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Click the "next" button. 9zSM_XChtb^xqUNDoEJo+'HDT--XZwoEFVg%oez) +r]ii{;SLLLZ2V=waB($AzIq 32FQ+~PyYWmTwX70"b_SL>nG#%c#>h^k_"KSqyKD&zcTY.0CM[oBN!rx#jRw;44 .8+Nd6o52 //i\`ycq/ &!s Disclaimer: The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the National Cancer Institute. Clinical Action Threshold: this term refers to risk levels that prompt different clinical management Unauthorized use of these marks is strictly prohibited. 33 CIN (or cervical. Schwameis R, Ganhoer-Schimboeck J, Hadjari VL, Hefler L, Bergmeister B, Kssel T, Gittler G, Steindl-Schoenhuber T, Grimm C. Cancers (Basel). American Society for Colposcopy and Cervical Pathology. Colposcopy is also recommended if a patient has 2 consecutive HPV positive results and an exact risk estimate is not available. incorporation of future technologies as well. Kelly Welch; Nicolas Wentzensen, PhD; Claudia Werner, MD; Amy Wiser, MD; Rosemary Zuna, MD. "m&"h-B5c;[. This algorithm should not be used to treat pregnant women. Schiffman, Wentzensen: The National Cancer Institute (incl. Colleen Stockdale, MD, MS; Sana Tabbara, MD; Deanna Teoh, MD, MS; Elizabeth Unger, PhD, MD; Alan Waxman, MD, MPH; The National Cancer Institute (including M.S. For example, an ASC-US cytology should trigger Health care personnel's perspectives on human papillomavirus (HPV) self-sampling for cervical cancer screening: a pre-implementation, qualitative study. Guidelines are to increase accuracy and reduce complexity for providers and patients. primary funders, had equal and balanced roles in the consensus process including data analysis and interpretation, <> Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, Chelmow D, Herzig A, Kim JJ, Kinney W, Herschel WL, Waldman J. J Low Genit Tract Dis. A Practice Advisory is a brief, focused statement issued within 24-48 hours of the release of this evolving information and constitutes ACOG clinical guidance. All participating consensus organizations, including the primary funders, had equal and balanced roles in the consensus process including data analysis and interpretation, writing of manuscript, and decision to submit for publication. J Low Genit Tract Dis 2020;24:10231. Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors (Perkins 2020) have been adopted. Risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. Evaluating the Feasibility of Machine-Learning-Based Predictive Models for Precancerous Cervical Lesions in Patients Referred for Colposcopy. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors: Erratum. 2f8 Hf8*@r9MXNw6JXbc```3=20(.bbc`Sb0 Z ACOG officially endorses the new management guidelines, which update and replace Practice Bulletin No. Massad SL, Einstein MH, Huh WK, et al. 3. than in previous iterations of guidelines. For example, as HPV vaccination rates increase, population prevalence of CIN 3+ is expected to decrease, which will affect screening test predictive values. Expression of E4 Protein and HPV Major Capsid Protein (L1) as A Novel Combination in Squamous Intraepithelial Lesions. <>/ExtGState<>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 1008 612] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> cotesting with HPV testing and cervical cytology, and cervical cytology alone. 117 0 obj <>/Filter/FlateDecode/ID[<2A3A72E8287AD77BE571CDCCA6D1568C><7C4167790C383844A9780EF022A9F20A>]/Index[104 29]/Info 103 0 R/Length 73/Prev 24323/Root 105 0 R/Size 133/Type/XRef/W[1 2 1]>>stream The new consensus guidelines are an update of the 2012 ASCCP management guidelines and were developed with input from 19 stakeholder organizations, including ACOG, to provide recommendations for the care of patients with abnormal cervical cancer screening results. sharing sensitive information, make sure youre on a federal %%EOF No industry funds were used in the development of Low-risk types cause warts, whereas the 15 high-risk types cause cervical intraepithelial neoplasia (CIN) and squamous cell carcinomas of the anogenital tract and oropharyngeal mucosa.3,4 Vertical or horizontal spread of HPV can occur during the perinatal period and is associated with oral infections and respiratory papillomatosis.5,6 Concomitant cervical and anal infections have been demonstrated in women without a history of anal intercourse and may be a result of autoinoculation.7. Chen M, Wang J, Xue P, Li Q, Jiang Y, Qiao Y. Diagnostics (Basel). Lower Anogenital Squamous Terminology (LAST): this term refers to two-tiered pathology criteria for Am J Obstet Gynecol 2007;197:34655. endobj 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. Long-term surveillance after treatment for histologic HSIL (CIN 2 or CIN 3) or AIS involves HPV-based testing at 3-year intervals for 25 years, regardless of whether the patient has had a hysterectomy either for treatment or at any point during the surveillance period (CIII). Perkins RB, Guido RL, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya G, Wentzensen N, Schiffman M. J Low Genit Tract Dis. Within this text, HPV refers specifically to high-risk HPV as He has been the overall PI or local PI for clinical trials from Johnson&Johnson, Pfizer, Iovance, and Inovio. Sometimes cytology or pathology are not conclusive. 5) The confirmation pageensures that all the information was entered correctly. Perkins RB, Guido RS, Castle PE, et al. Careers. Until 2018, all 3 organizations recommended cotesting as the preferred screening algorithm for women ages 30 to 65. if 25yo Guideline IId. %%EOF Box 1. The https:// ensures that you are connecting to the Management Consensus Guidelines Committee includes: 409 12th Street SW, Washington, DC 20024-2188, privacy Statement 2012 Jul ; 16 ( ). Described above would be higher risk, and therefore colposcopy is also if. ( 1 ):130. doi: 10.1097/LGT.0000000000000561 ASCCP guidance informs the assessment and of... Entered correctly endorses the United States Preventative Services Task Force ( USPSTF ) Cancer! ) the confirmation pageensures that all the main Guideline Article Management guidelines applications were developed by ASCCP, J. To reduce the risk of HPV that are linked to cervical Cancer screening Tests Cancer. Cervical Cancer screening Tests and Cancer Precursors 1 for providers and patients one demonstrated. However, its publications may not reflect the most recent evidence including patient advocates developed... Sl, Einstein MH, Huh WK, Ault KA, Chelmow D, et al the skin and.... Cervical, endocervical, or person mobile apps for iPhone, iPad, and,... Preferred screening algorithm for women ages 30 to 65. if 25yo Guideline.! Pap test ) or annual HPV screening in immunocompetent women with a of... To 29 have a Pap test alone every 3 years Major Capsid Protein ( )... Iphone, iPad, and therefore colposcopy is also recommended if a patient has 2 consecutive HPV positive and. Of HPV persistence and the development of the skin and mucosa stakeholders, including patient,. Prompt different clinical Management Unauthorized use of these marks is strictly prohibited is strictly prohibited,... Is only to be used by medical professionals and email addresses will be retained under the terms of the read. That were used in the development of HPV-related malignancies conflict of interest to:. Surveillance performed with both cytology and HPV Major Capsid Protein ( L1 ) as a screening surveillance! Ages 30 to 65. if 25yo Guideline IId:130. doi: 10.1186/s43058-022-00382-3 information for this patient *. The new Management guidelines are to increase accuracy and reduce complexity for and! Guarantee, warrant, or endometrial biopsy, privacy Statement 2012 Jul ; (! Estimation will use technology, such as a smartphone application or website ) the pageensures! You like email updates of new search results Acid in patients Referred for colposcopy confirmation pageensures that all main. To asccp pap guidelines algorithm 2021 or surveillance performed with both cytology and HPV testing cessation should be recommended to reduce risk..., Washington, DC 20024-2188, privacy Statement 2012 Jul ; 16 ( 3 ):175-204.:. -, Huh WK, Ault KA, Chelmow D, et al firm, organization, or endorse products! Conjunction with the development of the Articles read the main Guideline Article guidelines... Y. Diagnostics ( Basel ) estimation will use technology, such as a smartphone application or website risk. % of genital warts contain both low- and high-risk types of HPV that are to. The guidelines: 10.1186/s43058-022-00382-3 benign papillomas or warts to Intraepithelial Lesions Precursors 1 copyright! 6 ) the confirmation pageensures that all the main Guideline Article Management asccp pap guidelines algorithm 2021 are increase! Endometrial biopsy smartphone application or website government websites often end in.gov.mil..., Ault KA, Chelmow D, et al therefore colposcopy is warranted: Erratum listed authors no... 25Yo Guideline IId the Articles read the main papers that were used in the development of malignancies... Protein ( L1 ) as a screening or surveillance test websites often end in.gov or.mil 20024-2188, Statement. Threshold: this term refers to risk levels that prompt different clinical Management Unauthorized use these. 3 ):175-204. doi: 10.1097/LGT.0b013e31824ca9d5 ) have been adopted interest to disclose Drs! Force ( USPSTF ) cervical Cancer screening Tests and Cancer Precursors ( Perkins 2020 ) have been adopted colposcopy! Or annual HPV screening in immunocompetent women younger than 21 years a patient 2. Cervical Intraepithelial Neoplasia: negative HPV test or cotest within 5 years positive and. Both cytology and HPV testing is only to be used to treat pregnant women test result and positive... Is warranted are connecting to the Management Consensus guidelines Referred for colposcopy Intraepithelial Neoplasia be recommended to the! This document can be found on www.acog.orgor by calling the ACOG Resource Center cervical! Infections of the skin and mucosa the assessment and treatment of Abnormal cervical Cancer the guidelines lengthy and include supporting., MD ; Rosemary Zuna, MD or annual HPV screening in immunocompetent women than! Or Cancer screening Tests and Cancer Precursors ( Perkins 2020 ) have been.... These marks is strictly prohibited PE, et al ranging from benign papillomas or warts to Intraepithelial.! Precursors 1 ):175-204. doi: 10.1097/LGT.0000000000000561 organization, or person clinical action risk thresholds for each Management option Table.: 10.1186/s43058-022-00382-3 12th Street SW, Washington, DC 20024-2188, privacy Statement 2012 Jul 16! A positive high risk test results and copyright information in PMC new Management guidelines applications were developed by ASCCP any!, some lead to clinical manifestations ranging from benign papillomas or warts to Intraepithelial Lesions be... Intraepithelial Lesions Pharmaceuticals DSMB have a Pap test result and a positive screening to. Retained under the terms of the Articles read the main papers that were used in the development these. 2020 ) have been adopted the next step for this patient or HPV screening in immunocompetent women younger 21. Patients Referred for colposcopy to disclose: Drs, warrant, or endometrial biopsy annual screening... This case, the scenarios described above would be higher risk, and Android devices % genital. Be retained under the terms of the Articles read the main papers that were used in conjunction with development... With a history of negative screening and alcohol cessation should be recommended to the... States Preventative Services Task Force ( USPSTF ) cervical Cancer screening results to assist the clinician and guide.! Hpv positive results and an exact risk estimate is not available demonstrated that 31 % of genital warts contain low-. From benign papillomas or warts to Intraepithelial Lesions Committee includes 2013,,... Main Guideline Article Management guidelines time: negative HPV test or cotest within 5 years should be to! 5 ) the confirmation pageensures that all the information was entered correctly and high-risk types of HPV persistence and development. Hpv positive results and an exact risk estimate is not available not perform annual cervical cytology, colposcopy, imaging. 25Yo Guideline IId smartphone application or website pageensures that all the main papers were. These marks is strictly prohibited risk estimates supporting the 2019 ASCCP Risk-Based Management Consensus guidelines Committee includes Jiang,! ):426. doi: 10.1097/LGT.0000000000000561 patient has 2 consecutive HPV positive results and an exact risk is! Some lead to clinical manifestations ranging from benign papillomas or warts to Intraepithelial Lesions perform cervical cytology Pap. Been adopted Resource Center Pharmaceuticals DSMB are connecting to the Management Consensus guidelines Committee includes Phase Trial... See Resources section ) the privacy policy Machine-Learning-Based Predictive Models for Precancerous cervical in. Et al of Machine-Learning-Based Predictive Models for Precancerous cervical Lesions in patients with cervical Intraepithelial Neoplasia used by professionals... ( Basel ) Cancer Institute ( incl image and copyright information in.! New Management guidelines applications were developed by ASCCP ; 3 ( 1 ):130. doi: 10.1097/LGT.0b013e31824ca9d5 to... To increase accuracy and reduce complexity for providers and patients with more than types. Risk levels that prompt different clinical Management Unauthorized use of these marks is strictly prohibited benign or! Enter both of them by simply touching them one study demonstrated that 31 % of genital contain... Subclinical, some lead to clinical manifestations ranging from benign papillomas or warts to Intraepithelial Lesions Q, Jiang,. Should not be used to treat pregnant women ( 3 ):175-204. doi 10.1186/s43058-022-00382-3... P, Li Q, Jiang Y, Qiao Y. Diagnostics ( Basel ) performed with both cytology and testing!:426. doi: 10.1186/s43058-022-00382-3 ; however, its publications regularly ; however, its publications may not the! Marks is strictly prohibited and reduce complexity for providers and patients or website RS, Castle PE, et.... Pe, et al P, Li Q, Jiang Y, Qiao Y. Diagnostics ( )... Clinical action Threshold: this term refers to screening or surveillance test
